ACCP Announces New Board of Regents
Following a vote of the membership, the American College of Clinical Pharmacology® (ACCP) is pleased to announce the results of the 2022 Regents Election. Newly-elected Regents for the 2023 - 2027 term are:

  • Myong-Jin Kim, PharmD, FCP
  • Matthew B. Dufek, PhD, FCP

The primary responsibility of the Board of Regents is to set policy and annual or longer term goals and objectives, including but not limited to:

  • overseeing the transaction of business required to fulfill the purpose and objectives of ACCP;
  • regulating and conserving the property interest of ACCP;
  • overseeing expenditures and approving or disapproving the recommendations of Standing and other Committees.

Support and guidance from the Board of Regents will be critical as ACCP looks to the future and evolves to better serve the needs of its Members. The new Regents will begin a five-year term in February 2023. Please join us in congratulating Drs. Kim and Dufek in their new roles!
Myong-Jin Kim, PharmD, FCP
Director, Div of Therapeutic Performance II/ORS/OGD/CDER, US Food & Drug Administration

Dr. Kim became a Fellow of ACCP in 2017. Her ACCP activities include participation on the 2023 Annual Meeting Program Committee (2022 – present), the Honors & Awards Committee (2021 – 2022) and the Publications Committee (2017 – 2018). Dr. Kim has also served on the editorial board of The Journal of Clinical Pharmacology (JCP) since 2017 and has published 13 articles including the FDA Public Meeting Report on “Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications”. In 2020, she served as the co-guest editor of the JCP Supplement Issue on Women’s Health (2020, Volume 60, Issue S2). She has attended the 2017, 2018, 2020 and 2021 ACCP Annual Meetings.
Matthew B. Dufek, PhD, FCP
Senior Director of Clinical Development, Neuroscience Therapeutic Area, AbbVie Inc

Dr. Dufek joined ACCP in 2014 and became a Fellow in 2020. He served on the Students, Trainees & Early-stage Professionals Committee (2016 – 2018) and the Membership Committee (2018 – 2020) before assuming the chairmanship of the Membership Committee for 2020 – 2022. Dr. Dufek has participated in multiple working groups, task forces and subcommittees. He most recently led the development and implementation of the New Member ACCP Ambassador Program that welcomes New Members to ACCP and provides them with valuable information about getting involved in the society and making the best use of Member Benefits to grow their careers. He also frequently speaks at academic institutions about careers in clinical pharmacology and membership in ACCP. In addition to his committee involvement, Dr. Dufek has been a Faculty Speaker at the 2018 & 2019 ACCP Annual Meetings, a Panelist during the 2019 & 2020 Annual Meeting STEP events and a Poster Presenter at the 2018 Annual Meeting. In 2019, he was recognized in the ACCP Excellence in Achievement Program for his active participation and support of the society.
ACCP is a Member-focused/Member-driven clinical pharmacology society with 
Member Benefits that enhance your professional growth. Join today!
Stay Connected